BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 20513151)

  • 41. Bcl11b: A New Piece to the Complex Puzzle of Amyotrophic Lateral Sclerosis Neuropathogenesis?
    Lennon MJ; Jones SP; Lovelace MD; Guillemin GJ; Brew BJ
    Neurotox Res; 2016 Feb; 29(2):201-7. PubMed ID: 26563995
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of the transcription factor Bcl11b in development and lymphomagenesis.
    Kominami R
    Proc Jpn Acad Ser B Phys Biol Sci; 2012; 88(3):72-87. PubMed ID: 22450536
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Epigenetic Dynamics in the Function of T-Lineage Regulatory Factor Bcl11b.
    Sidwell T; Rothenberg EV
    Front Immunol; 2021; 12():669498. PubMed ID: 33936112
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The function of BCL11B in base excision repair contributes to its dual role as an oncogene and a haplo-insufficient tumor suppressor gene.
    Vickridge E; Faraco CCF; Lo F; Rahimian H; Liu ZY; Tehrani PS; Djerir B; Ramdzan ZM; Leduy L; Maréchal A; Gingras AC; Nepveu A
    Nucleic Acids Res; 2024 Jan; 52(1):223-242. PubMed ID: 37956270
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Majority of the Serine/Threonine Phosphorylation Sites in Bcl11b Protein Are Dispensable for the Differentiation of T Cells.
    Okuyama K; Nomura A; Nishino K; Tanaka H; Harly C; Chihara R; Harada Y; Muroi S; Kubo M; Kosako H; Taniuchi I
    J Immunol; 2023 Jun; 210(11):1728-1739. PubMed ID: 37074186
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pivotal role of BCL11B in the immune, hematopoietic and nervous systems: a review of the BCL11B-associated phenotypes from the genetic perspective.
    García-Aznar JM; Alonso Alvarez S; Bernal Del Castillo T
    Genes Immun; 2024 Jun; 25(3):232-241. PubMed ID: 38472338
    [TBL] [Abstract][Full Text] [Related]  

  • 47. BCL11B promotes T-cell acute lymphoblastic leukaemia cell survival via the XRCC5/C11ORF21 axis.
    Yu X; Li Y; Yang P; Wang Y; Liu X; Cai L; Lai J; Zhang Y; Zha X; Przybylski GK; Xu L; Li Y
    Clin Transl Med; 2024 Feb; 14(2):e1580. PubMed ID: 38317587
    [No Abstract]   [Full Text] [Related]  

  • 48. A Novel Germline Heterozygous
    Lu HY; Sertori R; Contreras AV; Hamer M; Messing M; Del Bel KL; Lopez-Rangel E; Chan ES; Rehmus W; Milner JD; McNagny KM; Lehman A; Wiest DL; Turvey SE
    Front Immunol; 2021; 12():788278. PubMed ID: 34887873
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of new modulators and protein alterations in non-apoptotic programmed cell death.
    Sperandio S; Poksay KS; Schilling B; Crippen D; Gibson BW; Bredesen DE
    J Cell Biochem; 2010 Dec; 111(6):1401-12. PubMed ID: 20830744
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Flow cytometry analysis of transcription factors in T lymphocytes.
    Albu DI; Califano D; Avram D
    Methods Mol Biol; 2010; 647():377-90. PubMed ID: 20694680
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bcl11b drives the birth of ILC2 innate lymphocytes.
    Zhong C; Zhu J
    J Exp Med; 2015 Jun; 212(6):828. PubMed ID: 26034114
    [No Abstract]   [Full Text] [Related]  

  • 52. An improved CUT&RUN method for regulation network reconstruction of low abundance transcription factor.
    Bai H; Lin M; Meng Y; Bai H; Cai S
    Cell Signal; 2022 Aug; 96():110361. PubMed ID: 35643226
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Analysis of the expression of PHTF1 and related genes in acute lymphoblastic leukemia.
    Huang X; Geng S; Weng J; Lu Z; Zeng L; Li M; Deng C; Wu X; Li Y; Du X
    Cancer Cell Int; 2015; 15():93. PubMed ID: 26448723
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long-range control of T-cell development.
    van Essen D
    Blood; 2013 Aug; 122(6):854-6. PubMed ID: 23929833
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Switch hitter: Bcl11b in T cells and ILC2s.
    Harly C; Bhandoola A
    J Exp Med; 2020 Jan; 217(1):. PubMed ID: 31828302
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Induction of Bcl11b during T cell commitment through a tripartite mechanism.
    Georgopoulos K
    Nat Immunol; 2016 Jul; 17(8):903-4. PubMed ID: 27434004
    [No Abstract]   [Full Text] [Related]  

  • 57. Inhibition of BCL11B induces downregulation of PTK7 and results in growth retardation and apoptosis in T-cell acute lymphoblastic leukemia.
    Li K; Chen C; Gao R; Yu X; Huang Y; Chen Z; Liu Z; Chen S; Luo G; Huang X; Przybylski GK; Li Y; Zeng C
    Biomark Res; 2021 Mar; 9(1):17. PubMed ID: 33663588
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bcl11b-A Critical Neurodevelopmental Transcription Factor-Roles in Health and Disease.
    Lennon MJ; Jones SP; Lovelace MD; Guillemin GJ; Brew BJ
    Front Cell Neurosci; 2017; 11():89. PubMed ID: 28424591
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reduced numatrin/B23/nucleophosmin labeling in apoptotic Jurkat T-lymphoblasts.
    Patterson SD; Grossman JS; D'Andrea P; Latter GI
    J Biol Chem; 1995 Apr; 270(16):9429-36. PubMed ID: 7721868
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Progressive Clinical and Neuroradiological Findings in a Child with BCL11B Missense Mutation: Expanding the Phenotypic Spectrum of Related Disorder.
    Alfei E; Cattaneo E; Spaccini L; Iascone M; Veggiotti P; Doneda C
    Neuropediatrics; 2022 Aug; 53(4):283-286. PubMed ID: 34844266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.